Navigation Links


Symphony at Biology News

Paying attention sets off symphony of cell synchronization

You know the sensation. When something has your full attention you see it vividly. And when you don't pay attention, you're liable to miss something important. Now a new Northwestern University study sheds light on how attention operates. The mystery of how attention improves the perception of incoming sensory stimulation has been a long-time concern of scientists. One hypothesis is that w...
Symphony at Biology Products
Symphony at Biology Technology

Symphony Corp. and CareEvolution to partner

A recent partnership between CareEvolution</...

Symphony Corp. moving into Fitchburg Technology Campus

Custom software developer Symphony CEO Ravi Kalla said in a press release that the space is going to be customized to make it possible to serve clients internatio...

Symphony Data merges with Atlanta outsourcing company

Madison-based Symphony Data Corp. has merged with STI Knowledge, an Atlanta-based provider of business process outsourcing (BPO) services.Symphony Data is a BPO company with offices in Norristown, Pennsylvania; Scottsdale, Arizona; and Hyderabad, India. Symphony Data was spun off from its parent Symphony Corp. Symphony Data is a provider of healthcare administrative and BPO services, wit...
Symphony at Medicine News

Paying Attention Sets Off Symphony of Cell Synchronization

You know the sensation. When something has your full attention you see it vividly. And when you don't pay attention, you're liable to miss something important//. Now a new Northwestern University study sheds light on how attention operates. The mystery of how attention improves the perception of incoming sensory stimulation has been a long-time concern of scientists. One hypothesis is...
Symphony at Medicine Products

Symphony I/C Graft Chambers

Description:The Symphony I/C Graft Chambers have been designed to work in conjunction with the Symphony Graft Delivery System and are available exclusively through LifeNet. Each I/C Graft Chamber is sold pre-filled with a mixture of allograft cancellous chips and demineralized allograft bone particles (DBM). The allograft tissue within the chamber possesses both osteoinductive and osteoconductive properties....
Company:DePuy Orthopaedics, Inc.

Symphony II

Description:Symphony II Platelet Concentrate System is a point-of-care system designed for the rapid preparation of Platelet Concentrate (also referred to as Platelet Rich Plasma - PRP) and Platelet Poor Plasma (PPP) from a small sample of blood. The Symphony II PCS concentrates the body's natural growth factors, which are found in the platelets. The platelet concentrate can be mixed with autograft and allog...
Company:DePuy Orthopaedics, Inc.

Symphony PCS

Description:Symphony Platelet Concentrate System is a point-of-care system designed for the rapid preparation of Platelet Concentrate (also referred to as Platelet Rich Plasma - PRP) and Platelet Poor Plasma (PPP) from a small sample of blood. The Symphony PCS concentrates the body's natural growth factors, which are found in the platelets. The platelet concentrate can be mixed with autograft and allograft b...
Company:DePuy Orthopaedics, Inc.

Symphony SR 2250

Description:With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new technologies, and delivering powerful monitoring....
Company:ELA Medical, Inc.

Symphony DR 2550

Description:With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new technologies, and delivering powerful monitoring. ELA dual chamber pacemakers are also indicated for dual-chamber and atrial tracking modes in patients who may benefit from maintenance of AV synchron...
Company:ELA Medical, Inc.

More>>

Symphony at Medicine Technology
Other TagsLaminectomy
(Date:12/2/2008)...Dec. 2 In an open lette...ation of Homes and Services for the Aging (AAHSA) ...ways that the Obama administration can make both s... the way America cares for its most vulnerable peo...xpand the Nation,s Work Force: Create Jobs in Agin...
(Date:12/2/2008).... 2 Today a group of h..., elected officials and other community leaders fr...n Detroit/Wayne County to solidify participants, u...and economic successes and challenges play a role ... the opening session of a three-day discussion to ...
(Date:12/2/2008)... better spent in other areas, experts say , ... rapid response teams, created to prevent cardiac ...ot seem to work, a new study finds. , "Many hos...decade," said lead researcher Dr. Paul S. Chan, a ... Kansas City, Mo. "Earlier studies had shown that ...
(Date:12/2/2008)... most were as effective, despite editorials urging...ay News) -- Brand-name drugs used to treat cardiov... review of available evidence shows. , Yet a nu... specialists, have urged against substituting the ...parts. , "We found no evidence that brand-name ...
Breaking Medicine News(10 mins):Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 2Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 3Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 3Health News:Generic Heart Drugs as Good as Brand-Name Counterparts 2Health News:Generic Heart Drugs as Good as Brand-Name Counterparts 3
(Date:12/2/2008)... anywhere else in the world. This is having a majo...n environment and effect of cities on rural areas....frica,s history is being over-looked. , Joy Clan...problem in the current issue of the African Journ...of the African population was rural, today 38% liv...
(Date:12/2/2008)...rmation due to climate change, pollution and human...een providing satellite data of the region for the...nation with ESA,s future missions will be key in i...policy called ,The European Union and the Arctic R...s in the region such as the opening up of long-sou...
(Date:12/1/2008)...idespread consumption advisories and uncertainty a... Now researchers at North Carolina State Universit... and regulators around the country predict which a...els a breakthrough that should help officials add...ories for specific water bodies and fish species. ...
(Date:12/1/2008)...l hold a colloquium to examine what lies ahead in ...ganisms. Leading researchers and students will dis...ibution and even evolution from the perspectives o...ersity informatics dealing with microbes, plants, ..., the event will take place at the Arnold and Mabe...
Breaking Biology News(10 mins):ESA satellites focusing on the Arctic 2New model predicts hot spots for mercury in fish 2Clinical Trial Data for Perforomist 28TM 29 Inhalation Solution to be Presented at ATS on May 20 2008 19587 1Clinical Trial Data for Perforomist 28TM 29 Inhalation Solution to be Presented at ATS on May 20 2008 19587 2Clinical Trial Data for Perforomist 28TM 29 Inhalation Solution to be Presented at ATS on May 20 2008 19587 3Clinical Trial Data for Perforomist 28TM 29 Inhalation Solution to be Presented at ATS on May 20 2008 19587 4Clinical Trial Data for Perforomist 28TM 29 Inhalation Solution to be Presented at ATS on May 20 2008 19587 5SemBioSys provides update on shrimp feed additive Immunosphere 28TM 29 5477 1SemBioSys provides update on shrimp feed additive Immunosphere 28TM 29 5477 2SemBioSys provides update on shrimp feed additive Immunosphere 28TM 29 5477 3Michael V Novinski Emisphere President CEO Featured in the Wall Street Transcript 5475 1Michael V Novinski Emisphere President CEO Featured in the Wall Street Transcript 5475 2Michael V Novinski Emisphere President CEO Featured in the Wall Street Transcript 5475 3Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate 28AT 1001 29 5473 1Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate 28AT 1001 29 5473 2Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate 28AT 1001 29 5473 3
Other Contentsfattyfattyfattyfattyfattyfattyfattyfecundityinhibitioninhibitioninhibitioninhibitioninhibitioninhibitioninhibitioninhibitioninhibitionfeedbackfeedbackfeedbackfeedbackfeedbackfeedbackfeedbackfeedbackfeedbackpatternpatternpatternpatternpatternpatternpatternpatternpatternfeedingfeedingfeedingfeedingfeedingfeedingfeedingfemurfemurfemurfemurfemurfertilizationfertilizationfertilizationfertilizationfertilizationfertilization